Stock Scorecard



Stock Summary for Abbvie Inc (ABBV) - $208.96 as of 4/6/2026 6:50:45 PM EST

Total Score

6 out of 30

Safety Score

64 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ABBV

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ABBV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ABBV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ABBV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ABBV (64 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 6
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ABBV

Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology 4/7/2026 12:00:00 PM
J.P. Morgan Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $260 4/7/2026 11:35:00 AM
TrumpRx adds medicines from AbbVie and Roche (ABBV:NYSE) 4/7/2026 11:29:00 AM
Biogen’s Apellis Deal And High Dose SPINRAZA Shift Growth Outlook 4/7/2026 10:41:00 AM
AbbVie Inc. $ABBV Shares Sold by Sound Income Strategies LLC 4/7/2026 10:32:00 AM
Assessing Regeneron Pharmaceuticals (REGN) Valuation After FDA Approval Extends EYLEA HD Dosing Intervals 4/7/2026 7:24:00 AM
AbbVie Inc. $ABBV Stake Lowered by Albion Financial Group UT 4/7/2026 7:06:00 AM
AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Analysts 4/7/2026 6:07:00 AM
AbbVie lowers Q1 and FY 2026 earnings outlook following $744M R&D charge 4/6/2026 10:06:00 PM
Healthcare, Financials ETFs Get A Mega-Cap Reset With TRUF, TRUH 4/6/2026 8:41:00 PM

Financial Details for ABBV

Company Overview

Ticker ABBV
Company Name Abbvie Inc
Country USA
Description AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Sector Name HEALTHCARE
Industry Name DRUG MANUFACTURERS - GENERAL
Most Recent Quarter 12/31/2025
Next Earnings Date 4/29/2026

Stock Price History

Last Day Price 208.96
Price 4 Years Ago 143.52
Last Day Price Updated 4/6/2026 6:50:45 PM EST
Last Day Volume 5,151,109
Average Daily Volume 7,039,831
52-Week High 241.12
52-Week Low 159.05
Last Price to 52 Week Low 31.38%

Valuation Measures

Trailing PE 88.49
Industry PE 28.25
Sector PE 65.47
5-Year Average PE 12.55
Free Cash Flow Ratio 70.59
Industry Free Cash Flow Ratio 26.60
Sector Free Cash Flow Ratio 27.44
Current Ratio Most Recent Quarter 0.67
Total Cash Per Share 2.96
Book Value Per Share Most Recent Quarter -1.85
Price to Book Ratio 50.46
Industry Price to Book Ratio 11.26
Sector Price to Book Ratio 36.09
Price to Sales Ratio Twelve Trailing Months 6.04
Industry Price to Sales Ratio Twelve Trailing Months 3.20
Sector Price to Sales Ratio Twelve Trailing Months 4.98
Analyst Buy Ratings 14
Analyst Strong Buy Ratings 8

Share Statistics

Total Shares Outstanding 1,768,762,000
Market Capitalization 369,600,507,520
Institutional Ownership 76.40%

Dividends

Ex-Dividend Date 4/15/2026
Previous Dividend Amount 1.7300
Current Dividend Amount 1.7300
Total Years Dividend Increasing Dividend Contender - Increasing for 13 Years
Trailing Annual Dividend Rate 6.65
Trailing Annual Dividend Yield 3.18%
Forward Annual Dividend Rate 6.92
Forward Annual Dividend Yield 3.31%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 2.89%
5-Year Average Dividend Yield 3.65%
1-Year Dividend Growth Rate Percentage 5.49%
3-Year Dividend Growth Rate Percentage 2.71%
5-Year Dividend Growth Rate Percentage 5.25%
All-Time Dividend Growth Rate Percentage 12.48%
Dividend Payout Ratio 281.78%

Income Statement

Quarterly Earnings Growth YOY -88.70%
Annual Earnings Growth -1.22%
Reported EPS 12 Trailing Months 2.36
Reported EPS Past Year 0.00
Reported EPS Prior Year 10.00
Net Income Twelve Trailing Months 4,226,000,000
Net Income Past Year 4,226,000,000
Net Income Prior Year 4,278,000,000
Quarterly Revenue Growth YOY 10.00%
5-Year Revenue Growth 5.95%
Operating Margin Twelve Trailing Months 34.10%

Balance Sheet

Total Cash Most Recent Quarter 5,229,000,000
Total Cash Past Year 5,229,000,000
Total Cash Prior Year 5,524,000,000
Net Cash Position Most Recent Quarter -53,712,000,000
Net Cash Position Past Year -53,712,000,000
Long Term Debt Past Year 58,941,000,000
Long Term Debt Prior Year 60,340,000,000
Total Debt Most Recent Quarter 58,941,000,000
Equity to Debt Ratio Past Year -0.06
Equity to Debt Ratio Most Recent Quarter -0.06
Total Stockholder Equity Past Year -3,270,000,000
Total Stockholder Equity Prior Year 3,325,000,000
Total Stockholder Equity Most Recent Quarter -3,270,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 17,693,000,000
Free Cash Flow Per Share Twelve Trailing Months 10.00
Free Cash Flow Past Year 17,816,000,000
Free Cash Flow Prior Year 17,832,000,000

Options

Put/Call Ratio 0.39
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -3.60
MACD Signal -3.68
20-Day Bollinger Lower Band 204.93
20-Day Bollinger Middle Band 220.94
20-Day Bollinger Upper Band 236.95
Beta 0.36
RSI 38.48
50-Day SMA 209.22
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 4/6/2026 4:17:55 PM EST